News

Citizens JMP analyst Silvan Tuerkcan reiterated a Buy rating on Exelixis today and set a price target of $50.00. The company’s shares closed yesterday at $44.39. Take advantage of TipRanks Premium at ...
Exelixis Inc (EXEL) reports robust financial results driven by the cabozantinib franchise, while navigating competitive and ...